XTalks
SEPTEMBER 14, 2022
Daxxify was FDA-approved for similar cosmetic purposes as Botox and other neuromodulators like Dysport and Xeomin. One of the first options made available for such purposes was Botox from Allergan, brought to health practitioners’ offices in 1989. A Novel Botox Competitor. Bringing Daxxify into Offices.
XTalks
JULY 5, 2022
Common anti-aging procedures include Botox or dermal fillers, which can reduce the appearance of wrinkles, sagging and increase volume in the face where desired. XTALKS WEBINAR: Diversity and Inclusion in Clinical Trials — Practical Steps for Patient Recruitment Strategies.
XTalks
AUGUST 2, 2023
This is largely due to failed trials as a prophylaxis resulting in the European Committee for Medical Products (CHMP) recommending against the approval of Lagevrio. percent increase since 2021, predominantly due to Botox sales for therapeutic uses. Botox was first approved by the FDA in 1989 for blepharospasms and strabismus in adults.
Expert insights. Personalized for you.
98 
Let's personalize your content